Cargando…

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome

Background: Obesity is an important part of polycystic ovary syndrome (PCOS) pathologies. The present study utilized the bioinformatics method to identify the molecular mechanism of obesity status in PCOS. Methods: Six transcriptome profiles of adipose tissue were obtained from online databases. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiaojiao, Huang, Xiaolin, Xue, Bingshuang, Wei, Yuhe, Hua, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148487/
https://www.ncbi.nlm.nih.gov/pubmed/33910166
http://dx.doi.org/10.18632/aging.202938
_version_ 1783697849748291584
author Zhou, Jiaojiao
Huang, Xiaolin
Xue, Bingshuang
Wei, Yuhe
Hua, Fei
author_facet Zhou, Jiaojiao
Huang, Xiaolin
Xue, Bingshuang
Wei, Yuhe
Hua, Fei
author_sort Zhou, Jiaojiao
collection PubMed
description Background: Obesity is an important part of polycystic ovary syndrome (PCOS) pathologies. The present study utilized the bioinformatics method to identify the molecular mechanism of obesity status in PCOS. Methods: Six transcriptome profiles of adipose tissue were obtained from online databases. The background correction and normalization were performed, and the DEGs were detected with the settings p < 0.05. The GO, KEGG pathway enrichment, and PPI network analysis were performed with the detected DEGs. Results: A total of 37 DGEs were found between obesity PCOS and healthy controls, and 8 of them were tested significant in the third database. The expression patterns of the 8 detected DGEs were then measured in another two datasets based on lean/obesity PCOS patients and healthy controls. The gene CHRDL1 was found to be in linear regression with the BMI index in PCOS patients (p = 0.0358), but such a difference was not found in healthy controls (p = 0.2487). The expression of CHRDL1 was significantly higher in obesity PCOS cases than the BMI matched healthy controls (p = 0.0415). Further enrichment research demonstrated the CHRDL1 might function as an inhibitor of the BMP4 or IGF1 signalling. Conclusion: In summary, the present study identified CHRDL1 as a candidate gene responsible for the obesity of PCOS patients.
format Online
Article
Text
id pubmed-8148487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-81484872021-05-26 Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome Zhou, Jiaojiao Huang, Xiaolin Xue, Bingshuang Wei, Yuhe Hua, Fei Aging (Albany NY) Research Paper Background: Obesity is an important part of polycystic ovary syndrome (PCOS) pathologies. The present study utilized the bioinformatics method to identify the molecular mechanism of obesity status in PCOS. Methods: Six transcriptome profiles of adipose tissue were obtained from online databases. The background correction and normalization were performed, and the DEGs were detected with the settings p < 0.05. The GO, KEGG pathway enrichment, and PPI network analysis were performed with the detected DEGs. Results: A total of 37 DGEs were found between obesity PCOS and healthy controls, and 8 of them were tested significant in the third database. The expression patterns of the 8 detected DGEs were then measured in another two datasets based on lean/obesity PCOS patients and healthy controls. The gene CHRDL1 was found to be in linear regression with the BMI index in PCOS patients (p = 0.0358), but such a difference was not found in healthy controls (p = 0.2487). The expression of CHRDL1 was significantly higher in obesity PCOS cases than the BMI matched healthy controls (p = 0.0415). Further enrichment research demonstrated the CHRDL1 might function as an inhibitor of the BMP4 or IGF1 signalling. Conclusion: In summary, the present study identified CHRDL1 as a candidate gene responsible for the obesity of PCOS patients. Impact Journals 2021-04-27 /pmc/articles/PMC8148487/ /pubmed/33910166 http://dx.doi.org/10.18632/aging.202938 Text en Copyright: © 2021 Zhou et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Zhou, Jiaojiao
Huang, Xiaolin
Xue, Bingshuang
Wei, Yuhe
Hua, Fei
Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title_full Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title_fullStr Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title_full_unstemmed Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title_short Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
title_sort bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148487/
https://www.ncbi.nlm.nih.gov/pubmed/33910166
http://dx.doi.org/10.18632/aging.202938
work_keys_str_mv AT zhoujiaojiao bioinformaticsanalysisofthemolecularmechanismofobesityinpolycysticovarysyndrome
AT huangxiaolin bioinformaticsanalysisofthemolecularmechanismofobesityinpolycysticovarysyndrome
AT xuebingshuang bioinformaticsanalysisofthemolecularmechanismofobesityinpolycysticovarysyndrome
AT weiyuhe bioinformaticsanalysisofthemolecularmechanismofobesityinpolycysticovarysyndrome
AT huafei bioinformaticsanalysisofthemolecularmechanismofobesityinpolycysticovarysyndrome